GIGABYTE
24.2.2020 16:02:10 CET | Business Wire | Press release
GIGABYTE was originally scheduled to exhibit its edge computing products, as well as data center solutions to seize the 5G opportunities at the Mobile World Congress (MWC) held at the end of February. Although the 2020 event is canceled by the GSMA, GIGABYTE made its show into a digital format, [GIGABYTE MWC Online](https://www.gigabyte.com/MWC/2020 ), allowing its partners, customers, and users to still see its latest developments for the 5G era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200224005042/en/
MWC is the world’s biggest exhibition for the telecommunications industry aimed to highlight how next-generation networks will form the basis of wide-reaching value creation and economic impact in the 5G era. GIGABYTE, being an enabler for digital era businesses to transform their core values seamlessly with the technology trends of tomorrow, wants to take the initiative to showcase its server solutions ready to be used as MEC (Multi-access Edge Computing) platforms to support the new generation of 5G technologies and services, leveraging its innovative hardware design together with NFV (Network Functions Virtualization) and open-source software stacks to meet the QoS requirements of 5G.
On The Edge of 5G
On [GIGABYTE MWC Online], the MEC products and solutions are embedded into an interactive map to illustrate how they fit into 5G scenarios of eMBB , URLLC , and mMTC . GIGABYTE offers one of industry’s most comprehensive server product lineups that can help businesses from different vertical markets to overcome the challenges of building data center infrastructure necessary for success in the 5G era. GIGABYTE’s G591-HS0, featuring support for up to 32 accelerator cards, can provide powerful compute capabilities to build a combined MEC / VR stitching / processing server, which allows for high resolution videos to be processed and stored locally on the baseband unit, therefore making it ideal for enabling live streaming of 8K video or 360 VR at large spectator events. GIGABYTE also launched a 5G CrowdCell with LimeNET, to overcome 5G’s weaknesses of short range and signal drop-offs when hitting concrete walls, further completes the eMBB scenario of next-generation spectator experience. GIGABYTE’s H242-Z10 is a prime example of a compact GPU accelerated edge server platform that can be deployed to connect an intelligent vehicles network in order to overcome performance limitations previously constrained by onboard vehicle processing, or the latency and transmission bottlenecks of cloud computing. Its ultra-small footprint form factor can be mass deployed at scale at the far edge, which is perfect to also be used as an mMTC server to support an IoT network to enable a smart city.
Data Center Know-How for 5G Era
GIGABYTE will establish its vital place in the 5G ecosystem through MEC-optimized server platforms. Moreover, GIGABYTE has long been an exceptional server hardware and solution provider that helps businesses to build the data center infrastructure that can accelerate their innovation in 5G. GIGABYTE’s software-defined storage solution can consolidate existing media and effortlessly add new capacity that supports all main storage types (block, object or file) while simplifying management and reducing infrastructure costs; and GIGABYTE’s DNN (Deep Neural Networks) Training Appliance is an on-premises AI development platform that combines high performance GPU servers and a user-friendly GUI with powerful optimizations to effectively improve the accuracy and reduce the time required for DNN training. Both of the server solutions are for businesses of all sizes to transition effortlessly into 5G, which promises endless possibilities and is the foundation of a new digitally driven industrial revolution featuring an era of Intelligent Connectivity – the convergence of AI, Big Data, and IoT – powered by 5G.
5G and AI to Make a Breakthrough in 2020
According to Deloitte’s market trend report last year, 2020 will be the year for 5G and Artificial Intelligence to take off; and MWC echoes on its website that the market for AI is projected to reach $70 billion by 2020. Intelligent Connectivity is a pivotal evolution of 5G, and Artificial Intelligence is poised to have a transformative effect on consumers, enterprises, and governments around the world.
GIGABYTE demonstrates on [GIGABYTE MWC Online] an eMBB scenario in which higher density, greater performance, and feature-rich computing can help accelerate applications that require increased bandwidth. As an NVIDIA EGX platform builder, GIGABYTE is able to showcase a secure, cloud native edge computing platform for IoT, AI, 3D, XR and beyond, featuring an integrated hardware and software stack which can be used to quickly & easily deploy ready-to-use containers and AI frameworks from NGC (NVIDIA GPU Cloud). And GIGABYTE’s AERO series laptop is the world’s first laptop powered by Microsoft Azure AI. Through machine learning, Azure will assist the AERO laptop to optimize system settings and control CPU & GPU’s power consumption to effectively improve users working environment, and ultimately define what a laptop should perform in the Intelligent Connectivity era of 5G.
Find Your 5G Edge
MEC is a key technology for 5G to come to its full implementation, and GIGABYTE wants to use [GIGABYTE MWC Online] as a portal to share its expert know-how and critical products and solutions, and showcase its data center knowledge that will help you "Find Your 5G Edge" to vindicate its capability to "Upgrade Your Life".
By February 24th , the website will be fully accessible for everyone to explore edge computing and 5G. GIGABYTE has transformed its MWC exhibition into an online experience, including filming marketing and product experts’ short footages to provide insights and share perspectives. Partners and customers who might have hoped to connect with GIGABYTE to discuss 5G possibilities can do so by filling out a short online form, and visitors and users can participate in an online event to learn more about GIGABYTE’s solutions and win an NVMe 1TB SDD.
About GIGABYTE
GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200224005042/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release
Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom